A latent variable model for improving inference in trials assessing the effect of dose on toxicity and composite efficacy endpoints.

Statistical Methods in Medical Research
James M S Wason, Shaun R Seaman

Abstract

It is often of interest to explore how dose affects the toxicity and efficacy properties of a novel treatment. In oncology, efficacy is often assessed through response, which is defined by a patient having no new tumour lesions and their tumour size shrinking by 30%. Usually response and toxicity are analysed as binary outcomes in early phase trials. Methods have been proposed to improve the efficiency of analysing response by utilising the continuous tumour size information instead of dichotomising it. However, these methods do not allow for toxicity or for different doses. Motivated by a phase II trial testing multiple doses of a treatment against placebo, we propose a latent variable model that can estimate the probability of response and no toxicity (or other related outcomes) for different doses. We assess the confidence interval coverage and efficiency properties of the method, compared to methods that do not use the continuous tumour size, in a simulation study and the real study. The coverage is close to nominal when model assumptions are met, although can be below nominal when the model is misspecified. Compared to methods that treat response as binary, the method has confidence intervals with 30-50% narrower widths. T...Continue Reading

References

Aug 3, 2004·Nature Reviews. Drug Discovery·Ismail Kola, John Landis
Sep 2, 2004·Biometrics·Peter F Thall, John D Cook
Oct 13, 2005·Statistics in Medicine·Wei ZhangSumithra Mandrekar
Aug 6, 2008·Statistics in Medicine·Vladimir DragalinYuehui Wu
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Dec 14, 2011·Statistics in Medicine·Valerii FedorovRongmei Zhang
Dec 20, 2011·Statistical Methods in Medical Research·James M S Wason, Adrian P Mander
Jun 2, 2012·Journal of Biopharmaceutical Statistics·Peter F Thall, Hoang Q Nguyen
Sep 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paulo M HoffMark P Saunders
Jun 19, 2013·Statistics in Medicine·James M S Wason, Shaun R Seaman
Jun 7, 2014·Journal of Biopharmaceutical Statistics·Nolan A Wages, Christopher Tait
Oct 7, 2015·Nature Reviews. Clinical Oncology·Alexia Iasonos, John O'Quigley
Oct 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bostjan SerugaIan F Tannock
Oct 22, 2015·Biostatistics·Suyu Liu, Valen E Johnson
Nov 11, 2015·Biostatistics·Juhee LeePeter Müller
Sep 20, 2016·Statistics in Medicine·Yong Zang, Ying Yuan
Mar 4, 2017·Journal of the Royal Statistical Society. Series C, Applied Statistics·Peter F ThallRalph G Zinner
May 24, 2018·Orphanet Journal of Rare Diseases·Martina McMenaminJames M S Wason

❮ Previous
Next ❯

Citations

Dec 8, 2021·BMC Rheumatology·Martina McMenaminJames M S Wason

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00384176

Software Mentioned

optim
R
Hmisc package R
AugBinDoseFinding

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.